The ocular and systemic features of 10
The treatment of choice in WG has been a combination of systemic corticosteroids and a lymphocytotoxic agent, of which cyclophosphamide is the most effective.216 Pulsed intravenous corticosteroids and cyclophosphamide,'7 and plasma exchange,'8 have also been used to control the acute phase of the disease.
In this study we describe the ocular and systemic features of a series of patients whose WG presented with anterior ocular disease. We also consider the consequences for ocular morbidity when treatment is directed against the underlying systemic disease. maxillary sinuses (6), epistaxis (6) , and deafness (3) .
Sinus x-rays revealed mucosal thickening or sinus pacification in five patients. Three cases had chest x-ray evidence of pulmonary consolidation, two with cavitation ( Fig 6) . Creatinine clearance indicated renal impairment in five patients.
Nasal mucosal biopsy provided histological confirmation of vasculitis in six patients and showed granuloma formation in five. Conjunctival biopsy (prior to referral) had shown vasculitis in a further case. The ANCA titre was also raised in all these patients. However, one had a normal titre at presentation, which was raised 18 months later. IIF could be demonrtgure DA Corneal gutterng central to areas of scleral necrosis with loss ofconjunctival cover (patient 7). Note collagen plug in corneal gutter (arrowed) and necrotic tissue emergingfrom conjunctival defects.
Figure 5B Same patient one week later, after two pulses of intravenous cyclophosphamide and methylprednisolone. The corneal plugfrom the nasal gutter has been lost, revealing a limbal perforation. strated in six cases, and in all of these c-ANCA was confirmed.
Ocular disease Scleritis. Scleral necrosis appeared to arise at a single focus, which evolved either by enlargement or by the development of satellite lesions (Fig SA) . Superior sclera was involved in four subjects, inferior in one and nasal in three. Ultrasound demonstrated spread to postequatorial sclera in two patients. Necrotic sclera appeared yellow when viewed with low intensity, diffuse light (Fig 3) . The overlying conjunctiva remained intact in two patients (Fig 3) but had become lost in five by the time of presentation (Figs 4, 5A, 7A).
Subconjunctival haemorrhage was present in five patients.
Limbal changes. The scleral necrosis transgressed the limbus in three patients (Fig 4) and evidence of limbal vascular remodelling was found in the remainder.
Corneal infiltrates. Multifocal stromal infiltrates below Bowman's membrane extended centrally from the limbus in every patient (Fig  3) . Disease activity was accompanied by enlargement of the infiltrates and loss of definition of their borders; Conversely, during periods of remission they became smaller and more discrete (Fig 7d) .
Corneal guttering was present in four patients. Gutters arose only central to areas of scleral necrosis (Fig 5A) . (Fig 3) .
Chest x-ray revealed multiple cavitating areas of pulmonary consolidation (Fig 6) , but sinus xrays were normal. The Case history: patient 8. Scleral necrosis, deafness, pulmonary cavitation, and renalfailure A 64-year-old man presented with a two-month history of arthralgia affecting his knees and elbows, nasal obstruction, and epistaxis, then soreness of both eyes and unilateral deafness. Visual acuities were 6/6 OD and 6/9 OS. There was bilateral superior scleral necrosis, with necrosis ofthe overlying conjunctiva, widespread pericapillary haemorrhages, and damage to the limbal vascular arcades (Fig 4) . Marginal corneal infiltrates were accompanied by early corneal gutter formation and mild anterior uveitis.
The ESR and CRP were raised and there were microscopic haematuria, proteinuria, and reduced creatinine clearance (20-5 ml/min). Chest x-ray showed a cavitating pulmonary lesion, and sinus x-rays showed antral mucosal thickening. The Non-steroidal anti-inflammatory agents had been used prior to admission in six patients but were never successful.
Oral steroids were used in all patients but alone never controlled acute disease. In two patients (without scleral necrosis) control was achieved by additional oral cyclophosphamide.
Pulsed immunosuppressive therapy (intravenous methylprednisolone and cyclophosphamide'9) was used in the seven patients, six with scleral necrosis, who had not responded to oral steroids and in whom scleritis was progressing rapidly. Intravenous injections of methylprednisolone (05-1-0 g) were repeated at three-day intervals until the scleritis had subsided: no more than four injections were ever required. Cyclophosphamide (0 5 g) usually accompanied the first two pulses of methylprednisolone. Oral prednisolone (15-20 mg) was started with the first pulse, and cyclophosphamide (2 mg/kg) was added when its intravenous administration ceased. This treatment acheived control of scleritis in all patients in whom it was used. Plasma exchange was used in two patients with severe progressive renal disease: one had received pulsed immunosuppressive therapy, which had appeared to control the scleritis but not the renal disease; the other presented in severe renal failure and was also treated with oral cyclophosphamide and prednisolone.
Azathioprine was substituted for cyclophosphamide in one patient in remission, and prompted an immediate relapse.
Surgery was required in one patient. A corneoscleral patch graft was performed for a limbal perforation after the disease had been controlled medically (Fig 5C) . CLINICAL 
PROGRESS
In areas of conjunctival necrosis exposed sclera became covered by fibrovascular tissue from adjacent conjunctiva. These neovascular membranes contracted, distorting the surrounding conjunctival vascular pattern ( Figs 7A, B, C) . Granulation tissue was pronounced in one patient (Fig 7B) . It arose in a zone ofscleral necrosis, was centred on a perforating deep scleral artery, and later became infarcted.
During remission marginal corneal infiltrates became smaller, better defined, and more refractile in nature but did not disappear completely (Fig 7D) . months). One (two cases) or two (two cases) further pulsed treatments were necessary in four patients.
Five patients had relapses of their systemic WG giving rise to acute renal failure (1), progressive renal failure (2), pericardial effusion (1) , rashes (1) , and arthralgia (3). One patient now requires haemodialysis.
Two out of 10 patients lost visual acuity in one eye after presentation: from 6/36 to counting fingers due to a macular hole secondary to cystoid macular oedema and uveitis in one; and from 6/24 to 5/60 due to retinal vascular occlusion complicating thrombocytosis in the other. Anterior segment changes such as guttering and perforation did not produce visual loss.
Intravenous methylprednisolone and cyclophosphamide were well tolerated apart from transient hyperglycaemia and electrolyte disturbances. Four patients became mildly cushingoid (with weight gain and facial changes), and one developed osteoporosis on prolonged systemic steroids. Alopecia was symptomatic in two patients. Pneumonia associated with cyclophosphamide-induced leucopenia and requiring admission to hospital arose in two patients. One patient suffered from herpes simplex virus pharyngitis. Later, when his WG was inactive, he died of a viral myocarditis. Although he was not severely leucopenic (leucocytes 3-3 x 109/dl), this may have been related to his immunosuppression. Discussion This paper considers the manner in which WG may present in an eye clinic, though our cases reflect a bias in this centre towards corneoscleral inflammatory disease. The mildest scleritis was accompanied by critical involvement of other systems, and even when no symptoms were volunteered they could be revealed by careful questioning. The discovery of systemic disease was vitally important to all our patients, and treatment ofthis, rather than the eye in isolation, reduced ocular morbidity.
The scleral changes with which these patients presented included episcleral vasodilatation and oedema, scleral oedema, and scleral necrosis, which was often accompanied by destruction of the overlying conjunctiva. Although conjunctival necrosis is a dramatic physical sign, the presence of scleral necrosis correlated best with the extent of systemic involvement.
It has been proposed that corneoscleral destructive disease straddling the limbus characterises systemic vasculitis.2021 Every patient with scleral necrosis did have multifocal, peripheral corneal infiltrates beneath Bowman's membrane, showing the vulnerability ofthe limbal arcades in this condition. This is to be the subject of a further paper. Corneal guttering arose less frequently, and always adjacent to necrotic sclera.
Although scleritis was the presenting symptom in all our patients, it was not responsible for visual loss. When this occurred, it resulted from cystoid macular oedema complicating uveitis in one case and retinal vascular occlusion in another. The latter was associated with reactive thrombocytosis, highlighting the susceptibility of damaged vascular beds to alterations in blood viscosity.
Despite their ophthalmological presentation, our patients gave histories revealing systemic disease, ANCA levels were raised, and investigations confirmed involvement of respiratory tract and kidneys in all but two. Our inclusion of two subjects (2, 10) with scleritis and raised ANCA titres, but without the full clinical criteria of Fauci et al, I reflects our view that this investigation may enable diagnosis earlier in the natural history of the disease. Both patients already had widespread vasculitis requiring systemic treatment.
CLINICAL ASSESSMENT
Although a careful history, and systemic and otolaryngological examination, exposed systemic inflammatory disease in our patients, further investigations were helpful in confirming the diagnosis and systems affected, and monitoring response to treatment.
Even in the absence ofsymptoms we frequently found radiological evidence of sinusitis or pulmonary cavitation. Renal impairment, which was found at presentation in most ofour patients, was also always asymptomatic. Half the patients had significant proteinuria, and creatinine clearance was reduced in seven out of 10.
Furthermore, renal disease was seen in patients with and without scleral necrosis: hence mild scleritis may be the presenting feature ofincipient renal failure.
The activity of WG is reported to be better estimated by CRP than ESR,"1 but both investigations proved equally sensitive during the assessment and management of our patients. Seven subjects presented with an ESR of over 80 mm/h, and two of the remainder were already on steroid therapy. In addition there was usually anaemia, leucocytosis, and thrombocytosis.
Immune complexes, complement, and serum immunoglobulins were raised in some patients, but, as in other studies, these were not consistent findings. 23 One patient had a positive test for rheumatoid factor, but with the exception of ANCA other autoantibodies were not found in our patients.
The initiation of long term immunosuppressive therapy demands confident diagnosis of the underlying systemic disease. In this study the anterior ocular inflammatory disease.
Wegener's granulomatosis presenting with Diagnosis and management of systemic 
